DA-3501

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameDA-3501
Drug Alias NameDA-3501DA3501AT-211
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionClaudin 18 protein modulators
TargetsClaudin-18 splice variant 2
Therapy Area/IndicationsStomach NeoplasmsEsophageal NeoplasmsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDong-A ST Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDong-A ST Co Ltd
Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsEsophageal NeoplasmsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A